Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement

Publication Date

2020

Journal Title

JAMA

Abstract

© 2020 American Medical Association. All rights reserved. Importance: Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance. Objective: To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults. Population: This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit. Recommendation: The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation).

Volume Number

323

Issue Number

10

Pages

970 - 975

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

General Internal Medicine

Additional Departments

Cardiology; Psychiatry

PMID

32119076

DOI

10.1001/jama.2020.1123

For the public and Northwell Health campuses

Share

COinS